Childhood Osteosarcoma
|
0.030 |
AlteredExpression
|
disease |
BEFREE |
Our research indicated that downexpression of miR-182-3p in OS cells results in overexpression of EBF2 and promotes the progression of OS.
|
30993113 |
2019 |
Obesity
|
0.010 |
Biomarker
|
disease |
BEFREE |
Overall, the study highlights the existence of novel regulatory mechanisms between Id1/PGC1α and Id1/Ebf2 in controlling brown fat metabolism, which has significant implications in the treatment of obesity and its associated diseases, such as diabetes.
|
28270523 |
2017 |
Diabetes
|
0.020 |
Biomarker
|
disease |
BEFREE |
Overall, the study highlights the existence of novel regulatory mechanisms between Id1/PGC1α and Id1/Ebf2 in controlling brown fat metabolism, which has significant implications in the treatment of obesity and its associated diseases, such as diabetes.
|
28270523 |
2017 |
Diabetes Mellitus
|
0.020 |
Biomarker
|
group |
BEFREE |
Overall, the study highlights the existence of novel regulatory mechanisms between Id1/PGC1α and Id1/Ebf2 in controlling brown fat metabolism, which has significant implications in the treatment of obesity and its associated diseases, such as diabetes.
|
28270523 |
2017 |
Mucocutaneous Lymph Node Syndrome
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
The present study investigated the association between KD and single nucleotide polymorphisms (SNPs) in the candidate gene early B cell factor 2 (EBF2), which is associated with inflammation markers.
|
29749135 |
2018 |
Lupus Erythematosus, Systemic
|
0.010 |
Biomarker
|
disease |
BEFREE |
There was a weak association between anti-EBF2 and SLE disease activity but no significant associations were determined for other measured IgG reactivity.
|
30041579 |
2018 |
Metastatic osteosarcoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
These results provided new therapeutic targets for metastatic osteosarcoma and insights into molecular regulation of EBF2.
|
30529043 |
2019 |
Anorectal Malformations
|
0.010 |
GeneticVariation
|
group |
BEFREE |
These results support that missense mutation in the EBF2 c.215C > T (p.Ala72Val) is very likely to contribute to the pathogenesis of ARM in this family.
|
29704291 |
2018 |
Peripheral Neuropathy
|
0.010 |
Biomarker
|
group |
BEFREE |
To get insight into Ebf2 function in peripheral nervous system, here we characterize the peripheral neuropathy affecting these mice.
|
21220016 |
2011 |
Peripheral Nervous System Diseases
|
0.010 |
Biomarker
|
group |
BEFREE |
To get insight into Ebf2 function in peripheral nervous system, here we characterize the peripheral neuropathy affecting these mice.
|
21220016 |
2011 |
Diabetes
|
0.020 |
Biomarker
|
disease |
BEFREE |
We demonstrate upregulation of the Knot ortholog EBF2 in glomeruli of human diabetic nephropathy patients and a mouse ob/ob diabetes model.
|
26190114 |
2015 |
Diabetes Mellitus
|
0.020 |
Biomarker
|
group |
BEFREE |
We demonstrate upregulation of the Knot ortholog EBF2 in glomeruli of human diabetic nephropathy patients and a mouse ob/ob diabetes model.
|
26190114 |
2015 |
Anus, Imperforate
|
0.310 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
We studied a Korean family with six affected members with imperforate anus across three generations by whole exome sequencing and identified a missense mutation in the EBF2 gene (c.215C > T; p.Ala72Val).
|
29704291 |
2018 |
Anus, Imperforate
|
0.310 |
GeneticVariation
|
disease |
BEFREE |
We studied a Korean family with six affected members with imperforate anus across three generations by whole exome sequencing and identified a missense mutation in the EBF2 gene (c.215C > T; p.Ala72Val).
|
29704291 |
2018 |